Protagonist Therapeutics, Inc (PTGX) Stock Price

44.99 ▼ -0.83 (-1.81%)
Open: 45.23 Vol: 739.46K Day's range: 43.4901 - 45.63 May 01, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PTGX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL NEUTRAL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 45.09▼ 45.03▼ 45.00▲ 45.06▼ 44.56▲
MA10 45.01▲ 44.99▲ 45.22▼ 45.42▼ 45.51▼
MA20 45.03▼ 45.18▼ 45.33▼ 44.70▲ 42.02▲
MA50 45.01▲ 45.01▼ 45.16▼ 45.82▼ 41.07▲
MA100 45.13▼ 45.19▼ 45.14▼ 42.29▲ 31.94▲
MA200 45.27▼ 44.88▲ 46.18▼ 42.64▲ 26.58▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.012▲ -0.031▼ -0.046▼ 0.030▲ 0.157▲
RSI 48.537▼ 47.650▼ 47.786▼ 47.679▼ 53.593▲
STOCH 80.260▲ 50.562     54.632     42.226     41.614    
WILL %R -47.826     -45.103     -45.103     -46.122     -58.030    
CCI 49.624     -4.406     -34.123     -38.860     15.829    
Latest Filters Detected On PTGX
RSI $PTGX RSI(14) Crossed Below 50 Set Alert
MA $PTGX Price Crossed Below MA(50) Set Alert
MA $PTGX Price Crossed Below MA(26) Set Alert
MA $PTGX Price Crossed Below MA(13) Set Alert
MA $PTGX Price Crossed Below MA(7) Set Alert
Protagonist Therapeutics, Inc News
E-Mini Nasdaq 100 Index Continuous Contract
Wednesday, April 30, 2025 03:51 AM
2-Year U.S. Treasury Note Continuous Contract $104.082 0.078 0.08% 5-Year U.S. Treasury Note Continuous Contract $109.227 0.133 0.12% 10-Year U.S. Treasury Note Continuous Contract $112.266 0.109 ...
Protagonist Therapeutics Stock Short Interest Report | NASDAQ:PTGX | Benzinga
Saturday, April 19, 2025 01:15 PM
Short interest in Protagonist Therapeutics Inc (NASDAQ:PTGX) decreased during the last reporting period, falling from 5.13M to 4.71M. This put 7.77% of the company's publicly available shares short.
Johnson & Johnson, Protagonist Tout Positive Results For Psoriasis Oral Pill Study
Thursday, April 10, 2025 03:19 AM
Protagonist Therapeutics, Inc. PTGX on Thursday announced new data for a pill that treats moderate-to-severe plaque psoriasis. The Phase 3 study was conducted in adolescents and adults simultaneously.
PTGX historical stock data
date open high low close volume
01/05/25 45.23 45.63 43.4901 44.99 739,458
30/04/25 45.25 46.015 44.2182 45.82 860,806
29/04/25 44.48 46.00 43.87 45.60 731,020
28/04/25 44.49 45.495 44.075 44.39 592,375
25/04/25 44.36 44.84 43.62 44.49 634,255
24/04/25 45.96 46.06 44.27 44.85 859,924
23/04/25 47.13 47.345 45.73 46.16 1,416,211
22/04/25 46.00 46.41 45.42 45.85 775,163
21/04/25 46.05 46.97 45.07 45.80 1,189,681
17/04/25 45.83 46.87 45.80 46.28 517,389
Quote Details
52wk Low:25.23
52wk High:60.60
Vol:739.46K
Avg Vol(3m):20.4M
1Y Chng:+40.79%
1M Chng:-15.19%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.80B